STOCK TITAN

Adastra Holdings Announces Resignation of Director

(Neutral)
(Neutral)
Tags
management

Adastra Holdings (OTC:XTXXF) announced that Paul Morgan has resigned as a director effective April 28, 2026. The company thanked Mr. Morgan for his service and said the remaining director is identifying candidates to fill board vacancies and will provide an update when available.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Langley, British Columbia--(Newsfile Corp. - April 29, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands with a focus on product innovation and commercialization for adult-use and medical markets, announces today that Paul Morgan has tendered his resignation as a director of the Company effective as of April 28, 2026. The Company thanks Mr. Morgan for his service as a member of the board of directors. The remaining director is in the process of identifying candidates to fill the vacancies and will provide an update once available.

About Adastra Holdings Ltd.

Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves non-medical and medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: www.adastraholdings.ca.

For additional information, please contact:
(778) 715 5011
info@adastraholdings.ca

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain "forward-looking information" as defined under applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding the identification of candidates to fill the vacancies on the board of directors and the Company's intention to provide an update once available. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; changes in consumer demand and preferences; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the Company's management's discussion and analysis for the nine months ended September 30, 2025, filed with Canadian securities regulators and available on the Company's profile on SEDAR+ at www.sedarplus.ca.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295015

FAQ

Who resigned from Adastra Holdings (XTXXF) and when did the resignation take effect?

Paul Morgan resigned from Adastra's board and his resignation was effective April 28, 2026, the company said. According to the company, the board expressed thanks for his service and noted that directors are seeking candidates to fill the vacancies.

How many directors remain on Adastra Holdings (XTXXF) after Paul Morgan's resignation?

The company reports that one remaining director is in place following the resignation of Paul Morgan. According to the company, that director is actively identifying candidates to fill the board vacancies and will provide updates when selections are made.

Will Adastra Holdings (XTXXF) provide updates about new board appointments and timing?

Adastra said it will provide an update once candidates to fill the vacancies are identified. According to the company, the remaining director is in the process of identifying candidates and will announce appointments when decisions are finalized.

Does Paul Morgan's resignation change Adastra Holdings' (XTXXF) business operations or governance now?

The announcement states the resignation is a board membership change effective April 28, 2026, without operational details. According to the company, the remaining director is seeking replacements and will update shareholders on any governance changes.